In Vivo Efficacy of ABT-255 against Drug-Sensitive and -Resistant Mycobacterium tuberculosis Strains

Current therapy for pulmonary tuberculosis involves 6 months of treatment with isoniazid, pyrazinamide, rifampin, and ethambutol or streptomycin for reliable treatment efficacy. The long treatment period increases the probability of noncompliance, leading to the generation of multidrug-resistant iso...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Oleksijew, Andy, Meulbroek, Jon, Ewing, Patty, Jarvis, Ken, Mitten, Mike, Paige, Lenette, Tovcimak, Ann, Nukkula, Mike, Chu, Daniel, Alder, Jeffrey D.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1998
Soggetti:	Experimental Therapeutics
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105917/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9756775/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.10.2674
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!